key: cord-0700054-czzjqqr6
authors: Benotmane, Ilies; Risch, Simone; Doderer‐Lang, Cécile; Caillard, Sophie; Fafi‐Kremer, Samira
title: Long‐term shedding of viable SARS‐CoV‐2 in kidney transplant recipients with COVID‐19
date: 2021-06-18
journal: Am J Transplant
DOI: 10.1111/ajt.16636
sha: 34fe06922207e03fb9f11e6897c39c7e0de8c1b8
doc_id: 700054
cord_uid: czzjqqr6

The exact duration of viable SARS‐CoV‐2 shedding in kidney transplant recipients (KTRs) remains unclear. Here, we retrospectively investigated this issue using cell cultures of SARS‐CoV‐2 RT‐PCR‐positive nasopharyngeal samples (n = 40) obtained from 16 KTRs with symptomatic COVID‐19 up to 39 days from symptom onset. A length of viable SARS‐CoV‐2 shedding >3 weeks from the onset of symptoms was identified in four KTRs (25%). These results suggest that a significant proportion of KTRs can shed viable SARS‐CoV‐2 for at least 3 weeks, which may favor the emergence of new variants. Based on these data, we recommend prolonging the isolation of KTRs with COVID‐19 until negative SARS‐CoV‐2 RT‐PCR testing.

Immunocompetent individuals with non-severe coronavirus disease 2019 (COVID-19) may shed SARS-CoV-2 for up to 10 days. 1, 2 Understanding whether immunocompromised kidney transplant recipients (KTRs) with COVID-19 may experience prolonged viral shedding has important public health implications, especially with respect to patient isolation. A previous study demonstrated that SARS-CoV-2 ribonucleic acid (RNA) was detectable for a longer period in nasopharyngeal swabs collected from KTRs than in those from immunocompetent individuals. 3 

Quantitative RT-PCR testing for SARS-CoV-2 was carried out according to the COVID-HUS study protocol (ClinicalTrials.gov identifier: NCT04405726) using nasopharyngeal swabs obtained at admission and, subsequently, on a weekly basis until discharge. Thereafter, RT-PCR testing was performed at 30 and 45 days (±7 days) from the onset of symptoms. We used an in-house RT-PCR-based assay targeting two different regions of the RNA-dependent RNA polymerase (RdRp) gene in accordance with the WHO technical guidance. Viral loads were quantified using the cycle threshold (Ct) values of the RdRp gene. Diagnostika GmbH) as previously described. 4 All experiments were carried out in a biosafety level-3 laboratory.

The study sample consisted of 16 KTR (88% men; median age: Table 1 . Table 1 .

Using in vitro cell cultures, we demonstrate that a significant pro- 

This study was supported by the Strasbourg University Hospital (COVID-HUS study-HUS N°7760).

The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. Dr Caillard reports personal fees and non-financial support from Novartis, nonfinancial support from Sanofi, and nonfinancial support from Astellas, unrelated to the current study. The other authors have no conflicts of interest to disclose. 

Virological assessment of hospitalized patients with COVID-2019

Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19

In-depth virological assessment of kidney transplant recipients with COVID-19

First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation

Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19

Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation

Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer

Centers for disease control and prevention

European Centre for Disease Prevention and Control. Guidance for discharge and ending of isolation of people with COVID-19

minar y-genom ic-chara cteri satio n-of-an-emerg ent-sars-cov-2-linea ge-in-the-uk-defin edby-a-novel -set-of-spike -mutat ions/563

Persistence and evolution of SARS-CoV-2 in an immunocompromised host

Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19

Correlation between 3790 quantitative polymerase chain reaction-positives samples and positive cell cultures, including 1941 severe acute respiratory syndrome coronavirus 2 isolates

Long-term shedding of viable SARS-CoV-2 in kidney